Das Vivantes Klinikum Am Urban ist das einzige Krankenhaus im Berliner Ortsteil Kreuzberg und wird vom landeseigenen Krankenhausbetreiber Vivantes betrieben. Rund 220 Ärzte und 360 Pflegekräfte sind in zwölf medizinischen Fachabteilungen und der zentralen Notaufnahme tätig.

During the past decade, Vivantes Klinikum am Urban conducted 28 clinical trials. In the 10-year time frame, 28 clinical trials started and 6 clinical trials were completed, i.e. on average, 21.4% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 5 clinical trials were completed. i.e. 38.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Vivantes Klinikum am Urban" #1 sponsor was "University of Ulm" with 4 trials, followed by "Biotronik SE & Co. KG" with 3 trials sponsored, "Boston Scientific Corporation" with 3 trials sponsored, "Stiftung Institut fuer Herzinfarktforschung" with 3 trials sponsored and "Stichting Hemato-Oncologie voor Volwassenen Nederland" with 3 trials sponsored. Other sponsors include 31 different institutions and companies that sponsored additional 41 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Vivantes Klinikum am Urban" #1 collaborator was "Deutsch-Österreichische Studiengruppe Akute Myeloische Leukämie (AMLSG)" with 2 trials as a collaborator, "Medtronic" with 2 trials as a collaborator, "University Hospital Tuebingen" with 2 trials as a collaborator, "ABX-CRO advanced pharmaceutical services Forschungsgesellschaft m.b.H." with 1 trials as a collaborator and "AbbVie" with 1 trials as a collaborator. Other collaborators include 28 different institutions and companies that were collaborators in the rest 38 trials.

According to Clinical.Site data, the most researched conditions in "Vivantes Klinikum am Urban" are "Prostate Cancer" (5 trials), "Acute Myeloid Leukemia" (4 trials), "Atrial Fibrillation" (4 trials), "Acute Myeloid Leukemia (AML)" (2 trials) and "Arrhythmia" (2 trials). Many other conditions were trialed in "Vivantes Klinikum am Urban" in a lesser frequency.

Most popular intervention types in "Vivantes Klinikum am Urban" are "Drug" (26 trials), "Device" (15 trials), "Other" (4 trials), "Procedure" (3 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Cytarabine" (2 trials), "Daunorubicin" (2 trials), "Docetaxel" (2 trials), "Ibrutinib" (2 trials) and "Placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "Vivantes Klinikum am Urban" are 42 trials for "All" genders, 8 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Vivantes Klinikum am Urban". undefined are not yet recruiting, 12 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 27 completed trials in Vivantes Klinikum am Urban, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Vivantes Klinikum am Urban, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 9 trials that are defined as “Not Applicable".